Biogen’s (BIIB) Immunology Bet Meets A Pricier Balance Sheet
On August 6, Biogen (NASDAQ:BIIB) completed its acquisition of RayThera, a privately held biotech developing small-molecule immunology therapies whose lead program entered Phase...
Posts Tagged ‘NASDAQ:BIIB’
Blowing Past the Street: 46 Stocks That Crushed Q2 EPS Projections
More than 250 companies announced their earnings performance in the second quarter of the year on Wednesday, July 29, offering a fresh look at how they performed relative to what...
10 Most Undervalued NASDAQ Stocks to Buy Right Now
In this article, we will discuss the 10 Most Undervalued NASDAQ Stocks to Buy Right Now.
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
In this article, we will discuss: 10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen.
Biogen Inc. (NASDAQ:BIIB) Q1 2026 Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q1 2026 Earnings Call Transcript April 29, 2026Biogen Inc. beats earnings expectations. Reported EPS is $3.57, expectations were $3.05.
Biogen Inc. (BIIB) Gets Upgraded by UBS on Upcoming Pipeline Catalysts
Biogen Inc. (NASDAQ:BIIB) is one of the best stem cell therapy stocks to buy. On April 22, Biogen Inc.
8 Best Stem Cell Therapy Stocks to Buy
In this article, we will look at the 8 Best Stem Cell Therapy Stocks to Buy.
Jim Cramer’s 17 Stock Calls: Applied Materials and CoreWeave
In this article, we will look at Jim Cramer’s stock calls on Mad Money recently.
What Makes Biogen (BIIB) an Attractive Long-Term Holding?
Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter.
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s Why
Biogen Inc. (NASDAQ:BIIB) is one of the best medical research stocks to buy according to hedge funds. On February 10, Wedbush lifted the price target on Biogen Inc.
10 Best Medical Research Stocks to Buy According to Hedge Funds
In this article, we will look at the 10 Best Medical Research Stocks to Buy According to Hedge Funds.
Biogen Inc. (NASDAQ:BIIB) Q4 2025 Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q4 2025 Earnings Call Transcript February 6, 2026Biogen Inc. beats earnings expectations. Reported EPS is $1.99, expectations were $1.61.
Here’s What Analysts Think About Biogen Inc. (BIIB)
Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on January 8.
10 Best Performing Pharma Stocks in 2025
In this article, we will look at the 10 Best Performing Pharma Stocks in 2025.
HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress
We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now.
9 Most Undervalued Pharma Stocks to Buy Right Now
In this article, we will be taking a look at the 9 Most Undervalued Pharma Stocks to Buy Right Now. The U.S.
Biogen Inc. (NASDAQ:BIIB) Q3 2025 Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q3 2025 Earnings Call Transcript October 30, 2025Biogen Inc. beats earnings expectations. Reported EPS is $4.81, expectations were $3.89.
Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT
With significant upside potential, Biogen Inc. (NASDAQ:BIIB) secures a spot on our list of the 12 Best Widow and Orphan Stocks to Buy According to Analysts.
12 Best Widow and Orphan Stocks to Buy According to Analysts
In this article, we explore the 12 Best Widow and Orphan Stocks to Buy According to Analysts. According to Reuters, U.S. stock index futures increased on September 29.
Biogen Inc. (BIIB): A Bull Case Theory
We came across a bullish thesis on Biogen Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on BIIB.
Biogen (BIIB) Expands Neurology Pipeline With Alcyone Buyout, Stock Seen Undervalued
Biogen Inc. (NASDAQ:BIIB) ranks among the most undervalued NASDAQ stocks to buy now. On September 18, Biogen Inc.
14 Most Undervalued NASDAQ Stocks to Buy Now
In this article, we will take a look at the 14 Most Undervalued NASDAQ Stocks to Buy Now.
Canaccord Genuity Reiterates a Buy on Biogen (BIIB)
Biogen Inc. (NASDAQ:BIIB) is one of the best drug stocks to buy right now.
H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects
Biogen Inc. (NASDAQ:BIIB) is one of the best defensive stocks to buy, according to Steve Cohen. On September 5, H.C.
12 Best Drug Stocks to Buy Right Now
In this article, we will look at the 12 Best Drug Stocks to Buy Right Now. On September 10, FDA Commissioner Dr.
10 Best Defensive Stocks to Buy According to Steve Cohen
In this article, we discuss the 10 Best Defensive Stocks to Buy According to Steve Cohen.
Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries
We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Biogen Inc. is one of them. Biogen Inc.
10 High Growth Pharma Stocks That Are Profitable in 2025
In this article, we will be taking a look at the 10 High Growth Pharma Stocks That Are Profitable in 2025.
Biogen (BIIB) Price Target Hiked to $130 at UBS amid Leqembi Development
Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts.
Top 10 Medical AI Companies to Buy According to Analysts
In this article, we will look at the Top 10 Medical AI Companies to Buy According to Analysts.
Biogen Inc. (BIIB): A Bull Case Theory
We came across a bullish thesis on Biogen Inc. on r/Valueinvesting subreddit by U/Lobyous. In this article, we will summarize the bulls’ thesis on BIIB.
BofA Lowers PT on Biogen (BIIB) to $142 From $143, Keeps a Neutral Rating
Biogen Inc. (NASDAQ:BIIB) is one of the top cheap pharmaceutical stocks to buy now. BofA lowered the firm’s price target on Biogen Inc.
11 Cheap Pharmaceutical Stocks to Buy Now
In this article, we will look at the 11 Cheap Pharmaceutical Stocks to Buy Now.
Biogen Inc. (NASDAQ:BIIB) Q2 2025 Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q2 2025 Earnings Call Transcript July 31, 2025Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $3.93.
Biogen (BIIB) to Invest $2 Billion in U.S. Expansion Amid Onshoring Push
Biogen Inc. (NASDAQ:BIIB) ranks among the stocks to benefit from an onshoring boom. On July 21, Biogen Inc.
Tariff Stocks: 20 Stocks to Benefit From Onshoring Boom
In this article, we will take a look at the 20 stocks that will benefit from an onshoring boom. U.S.
Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most undervalued stocks. Biogen Inc.
10 Most Undervalued Pharma Stocks to Buy Now
In this article, we will be taking a look at the 10 Most Undervalued Pharma Stocks to Buy Now. Pharmaceutical manufacturing in the U.S.
RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT
Biogen Inc. (NASDAQ:BIIB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential.
13 Cheap Healthcare Stocks with Huge Upside Potential
In this article, we will look at the 13 Cheap Healthcare Stocks with Huge Upside Potential.
Biogen Advances Once-Yearly SMA Therapy Salanersen to Phase 3 After Positive Phase 1 Results
Biogen Inc. (NASDAQ:BIIB) is one of the most undervalued US stocks according to analysts.
11 Most Undervalued US Stocks According to Analysts
On June 26, Noah Blackstein, Dynamic Funds senior portfolio manager, joined CNBC's 'Squawk Box' to discuss the current market and economic conditions.
Biogen’s Friedreich’s Ataxia Campaigns Earn 4 Cannes Lions Pharma Nominations
Biogen Inc. (NASDAQ:BIIB) is one of the best S&P 500 stocks with huge upside potential.
12 Best S&P 500 Stocks With Huge Upside Potential
Bankim Chadha, Deutsche Bank's chief global strategist, joined CNBC's 'The Exchange' on June 24 to express a cautionary view regarding further monetary policy movement despite...
Biogen Launches Phase 3 Pediatric Trial Of Omaveloxolone For Friedreich Ataxia.
Biogen Inc. (NASDAQ:BIIB) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.
11 Best Genomics Stocks to Buy According to Hedge Funds
In this article, we will discuss: 11 Best Genomics Stocks to Buy According to Hedge Funds Genomics is the study of genes and how they operate.
Biogen Targets Rare Diseases, Eyes $800M Cost Cuts With ‘Fit for Growth’ Plan
Biogen Inc. (NASDAQ:BIIB) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Biogen Inc.
Biogen, UCB Present Positive Phase 3 Results for Lupus Drug Candidate at EULAR 2025
Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now.
11 Most Profitable NASDAQ Stocks to Buy Now
Earlier on May 30, Siebert Financial CIO Mark Malek appeared on CNBC to discuss the tariff headwinds swirling around the markets and which sectors could then rise above the noise...
15 Best Stocks to Invest in for an 18 Year Old
In this article, we will take a look at the 15 Best Stocks to Invest in for an 18 Year Old.
Hedge Fund Resource Center
